Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT01784068 ENESTfreedom — Nilotinib Treatment-free Remission Study in CML (Chronic… |
Nilotinib followed by treatment-f… | Cancer | Phase 2 | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Austria, Belgium, Bulgaria,… | 2013-03-19 → 2025-01-23 | Ouvrir |
| NCT07147231 Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461),… |
Biopsy Procedure | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Emory Saint Joseph's Hospital, Atlant… | 2026-08-10 → 2027-09-30 | Ouvrir |
| NCT06956001 Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatmen… |
Firmonertinib Mesilate Tablets | Cancer | Phase 3 | RECRUITING | En attente / non publié | Allist Pharmaceuticals, Inc. | China · Ethics Committee of cancer hospital, Chinese … | 2024-11-19 → 2028-07 | Ouvrir |
| NCT03409432 Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB… |
Brentuximab Vedotin | Cancer | Phase 2 | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · Ohio State University Comprehensive C… | 2018-03-16 → 2025-07-16 | Ouvrir |
| NCT07696715 TIME-NL — Timing of Immunotherapy in Melanoma |
TIME-NL — Timing of Immunotherapy… | Cancer | Non applicable | RECRUITING | En attente / non publié | Radboud University Medical Center | Netherlands · Amsterdam UMC, Amsterdam, Netherlands |… | 2026-08-10 → 2033-09-30 | Ouvrir |
| NCT07761988 The FamilyStrong Pilot Randomized Trial |
The FamilyStrong Pilot Randomized… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Alabama at Birmingh… | United States · University of Alabama at Birmingham, … | 2027-01-01 → 2028-09-30 | Ouvrir |
| NCT07716579 Assessment of Endocrine and Metabolic Late Effects After Childhood Brai… |
Assessment of Endocrine and Metab… | Cancer | Non applicable | COMPLETED | En attente / non publié | Institute of Oncology Ljubljana | Slovenia · Institute of Oncology Ljubljana, Ljubljana… | 2023-07-03 → 2025-12-31 | Ouvrir |
| NCT07391774 Testing Whether Hormone Therapy With Ribociclib is as Effective as Chem… |
Anastrozole | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Puerto Rico · Abbott-Northwestern Hosp… | 2026-08-10 → 2029-07-31 | Ouvrir |
| NCT07428356 HALT — Histotripsy for Ablation of Liver Tumours in Asia |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | RECRUITING | En attente / non publié | HistoSonics, Inc. | Singapore · National Cancer Centre Singapore, Singapo… | 2025-11-07 → 2029-05-07 | Ouvrir |
| NCT07180706 To Evaluate the Safety and Efficacy of Histotripsy for the Symptom Reli… |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | HistoSonics, Inc. | Taiwan · National Taiwan University Hospital, Taipei,… | 2025-10-01 → 2027-07-31 | Ouvrir |
| NCT06282809 GANNON — The HistoSonics Edison™ System for Treatment of Pancreatic Ade… |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | RECRUITING | En attente / non publié | HistoSonics, Inc. | Spain · Hospital de la Santa Creu i Sant Pau, Barcelo… | 2024-12-10 → 2028-08 | Ouvrir |
| NCT05820087 The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tum… |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | HistoSonics, Inc. | United States · AdventHealth Celebration, Celebration… | 2024-01-04 → 2030-07 | Ouvrir |
| NCT05432232 CAIN — The HistoSonics Investigational System for Treatment of Primary … |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | COMPLETED | En attente / non publié | HistoSonics, Inc. | United Kingdom · Leeds Teaching Hospitals NHS Trust, … | 2023-03-23 → 2025-06-06 | Ouvrir |
| NCT04573881 The HistoSonics System for Treatment of Primary and Metastatic Liver Tu… |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | HistoSonics, Inc. | Germany, Italy, Spain, United Kingdom · Istituto Clin… | 2021-06-04 → 2027-08 | Ouvrir |
| NCT04572633 #HOPE4LIVER US — The HistoSonics System for Treatment of Primary and Me… |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | HistoSonics, Inc. | United States · Medical College of Wisconsin/Froedter… | 2021-01-27 → 2027-09 | Ouvrir |
| NCT05482477 TEAS — Timing of Transcutaneous Acupoint Electrical Stimulation on Post… |
TEAS — Timing of Transcutaneous A… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Subei People's Hospital of Jiangs… | China · Northern Jiangsu People's Hospital, Yangz… | 2025-01-01 → 2026-12-30 | Ouvrir |
| NCT06623422 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene … |
Pembrolizumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Belgium, Brazil,… | 2024-10-21 → 2038-01-26 | Ouvrir |
| NCT06989112 DE-01 — DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxte… |
Trastuzumab deruxtecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Australia, Austria, Belgium, Brazil, C… | 2025-03-27 → 2031-02-19 | Ouvrir |
| NCT04924101 Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Com… |
Pembrolizumab | Parkinson | Phase 2 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Austria, Canada, Hungary, Israel, Ital… | 2021-07-15 → 2025-06-23 | Ouvrir |
| NCT01465087 Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmu… |
Nanotechnology for Detection of M… | SEP | Non applicable | COMPLETED | En attente / non publié | Carmel Medical Center | Israel · Multiple Sclerosis Clinic, Carmel Medical Ce… | 2011-12 → 2015-01 | Ouvrir |
| NCT07439328 ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Gra… |
ASTRA Study: Circulating Tumor Ce… | Cancer | NA | COMPLETED | En attente / non publié | Institute of Oncology Ljubljana | Slovenia · Institute of Oncology Ljubljana, Ljubljana… | 2024-01-01 → 2025-12-31 | Ouvrir |
| NCT06828328 A Study of GC203 TIL in PDCA (RJ) |
GC203 TIL | Cancer | Phase 1 | RECRUITING | En attente / non publié | Shanghai Juncell Therapeutics | China · Ruijin Hospital, Shanghai, China | 2025-02-10 → 2028-01-31 | Ouvrir |
| NCT00874328 A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With St… |
Irinotecan | Cancer | Phase 1 | UNKNOWN | En attente / non publié | Merck Sharp & Dohme LLC | South Korea · ASAN Medical Center, Seoul, South Korea | 2008-10 → 2012-12 | Ouvrir |
| NCT04078230 Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cho… |
Extend LymphAdenectomy | Cancer | NA | RECRUITING | En attente / non publié | Second Affiliated Hospital, Zheji… | United States, China · China-Japan Friendship Hospita… | 2020-01-01 → 2027-12-31 | Ouvrir |
| NCT00987428 EEPAB2 — Early Endoscopic Ultrasound - Based Sphincterotomy or Conserva… |
ultrasonography with or not sphin… | Cancer | NA | TERMINATED | En attente / non publié | Assistance Publique - Hôpitaux de… | France · Hôpital Cochin, Paris, France | 2009-08 → 2012-03 | Ouvrir |